We extract from data the parameters of the Higgs potential, the top Yukawa coupling and the electroweak gauge couplings with full 2-loop NNLO precision, and we extrapolate the SM parameters up to large energies with full 3-loop NNLO RGE precision. Then we study the phase diagram of the Standard Model in terms of high-energy parameters, finding that the measured Higgs mass roughly corresponds to the minimum values of the Higgs quartic and top Yukawa and the maximum value of the gauge couplings allowed by vacuum metastability. We discuss various theoretical interpretations of the near-criticality of the Higgs mass.
Abstract:We explore the possibility that the fundamental theory of nature does not contain any scale. This implies a renormalizable quantum gravity theory where the graviton kinetic term has 4 derivatives, and can be reinterpreted as gravity minus an anti-graviton. We compute the super-Planckian RGE of adimensional gravity coupled to a generic matter sector. The Planck scale and a flat space can arise dynamically at quantum level provided that a quartic scalar coupling and its β function vanish at the Planck scale. This is how the Higgs boson behaves for M h ≈ 125 GeV and M t ≈ 171 GeV. Within agravity, inflation is a generic phenomenon: the slow-roll parameters are given by the β-functions of the theory, and are small if couplings are perturbative. The predictions n s ≈ 0.967 and r ≈ 0.13 arise if the inflaton is identified with the Higgs of gravity. Furthermore, quadratically divergent corrections to the Higgs mass vanish: a small weak scale is natural and can be generated by agravity quantum corrections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.